Calliditas Therapeutics AB (publ)

OM:CALTX 주식 보고서

시가총액: SEK 11.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Calliditas Therapeutics 관리

관리 기준 확인 2/4

Calliditas Therapeutics' CEO는 Renee Aguiar-Lucander, May2017 에 임명되었습니다 의 임기는 7.08 년입니다. 총 연간 보상은 SEK 18.37M, 36.6% 로 구성됩니다. 36.6% 급여 및 63.4% 보너스(회사 주식 및 옵션 포함). 는 SEK 131.56M 가치에 해당하는 회사 주식의 1.2% 직접 소유합니다. 131.56M. 경영진과 이사회의 평균 재임 기간은 각각 3.3 년과 5.1 년입니다.

주요 정보

Renee Aguiar-Lucander

최고 경영자

SEK 18.4m

총 보상

CEO 급여 비율36.6%
CEO 임기7.2yrs
CEO 소유권1.2%
경영진 평균 재임 기간3.3yrs
이사회 평균 재임 기간5.2yrs

최근 관리 업데이트

Recent updates

Analysts Have Lowered Expectations For Calliditas Therapeutics AB (publ) (STO:CALTX) After Its Latest Results

Feb 24
Analysts Have Lowered Expectations For Calliditas Therapeutics AB (publ) (STO:CALTX) After Its Latest Results

Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Jan 12
Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Market Might Still Lack Some Conviction On Calliditas Therapeutics AB (publ) (STO:CALTX) Even After 42% Share Price Boost

Dec 22
Market Might Still Lack Some Conviction On Calliditas Therapeutics AB (publ) (STO:CALTX) Even After 42% Share Price Boost

Is Calliditas Therapeutics (STO:CALTX) Weighed On By Its Debt Load?

Sep 22
Is Calliditas Therapeutics (STO:CALTX) Weighed On By Its Debt Load?

What You Need To Know About The Calliditas Therapeutics AB (publ) (STO:CALTX) Analyst Downgrade Today

Aug 19
What You Need To Know About The Calliditas Therapeutics AB (publ) (STO:CALTX) Analyst Downgrade Today

Investors Don't See Light At End Of Calliditas Therapeutics AB (publ)'s (STO:CALTX) Tunnel And Push Stock Down 26%

May 26
Investors Don't See Light At End Of Calliditas Therapeutics AB (publ)'s (STO:CALTX) Tunnel And Push Stock Down 26%

Is Calliditas Therapeutics (STO:CALTX) Using Debt Sensibly?

Feb 24
Is Calliditas Therapeutics (STO:CALTX) Using Debt Sensibly?

Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Nov 25
Health Check: How Prudently Does Calliditas Therapeutics (STO:CALTX) Use Debt?

Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Just Slashed This Year's Revenue Estimates By 19%

Aug 24
Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Just Slashed This Year's Revenue Estimates By 19%

Is Calliditas Therapeutics (STO:CALTX) Using Too Much Debt?

Aug 03
Is Calliditas Therapeutics (STO:CALTX) Using Too Much Debt?

Is Calliditas Therapeutics (STO:CALTX) A Risky Investment?

Apr 24
Is Calliditas Therapeutics (STO:CALTX) A Risky Investment?

Need To Know: The Consensus Just Cut Its Calliditas Therapeutics AB (publ) (STO:CALTX) Estimates For 2022

Mar 19
Need To Know: The Consensus Just Cut Its Calliditas Therapeutics AB (publ) (STO:CALTX) Estimates For 2022

Analysts' Revenue Estimates For Calliditas Therapeutics AB (publ) (STO:CALTX) Are Surging Higher

Feb 28
Analysts' Revenue Estimates For Calliditas Therapeutics AB (publ) (STO:CALTX) Are Surging Higher

Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 27
Calliditas Therapeutics AB (publ) (STO:CALTX) Analysts Are Pretty Bullish On The Stock After Recent Results

CEO 보상 분석

Renee Aguiar-Lucander 의 보수는 Calliditas Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-SEK 525m

Dec 31 2023SEK 18mSEK 7m

-SEK 466m

Sep 30 2023n/an/a

-SEK 451m

Jun 30 2023n/an/a

-SEK 292m

Mar 31 2023n/an/a

-SEK 393m

Dec 31 2022SEK 13mSEK 6m

-SEK 412m

Sep 30 2022n/an/a

-SEK 628m

Jun 30 2022n/an/a

-SEK 608m

Mar 31 2022n/an/a

-SEK 576m

Dec 31 2021SEK 11mSEK 5m

-SEK 500m

Sep 30 2021n/an/a

-SEK 452m

Jun 30 2021n/an/a

-SEK 600m

Mar 31 2021n/an/a

-SEK 501m

Dec 31 2020SEK 7mSEK 3m

-SEK 433m

Sep 30 2020n/an/a

-SEK 286m

Jun 30 2020n/an/a

-SEK 198m

Mar 31 2020n/an/a

-SEK 54m

Dec 31 2019SEK 4mSEK 3m

-SEK 33m

Sep 30 2019n/an/a

-SEK 54m

Jun 30 2019n/an/a

-SEK 35m

Mar 31 2019n/an/a

-SEK 136m

Dec 31 2018SEK 4mSEK 2m

-SEK 132m

보상 대 시장: Renee 의 총 보상 ($USD 1.76M )은 Swedish 시장( $USD 759.84K ).

보상과 수익: 회사가 수익성이 없는 동안 Renee 의 보상이 증가했습니다.

CEO

Renee Aguiar-Lucander (62 yo)

7.2yrs

테뉴어

SEK 18,367,000

보상

Ms. Renee Aguiar-Lucander serves as Director at Genkyotex SA since November 2020. Ms. Aguiar-Lucander has been Chief Executive Officer of Calliditas Therapeutics AB (publ) since May 2017. Prior to joining...

리더십 팀

이름위치테뉴어보상소유권
Renee Aguiar-Lucander
Chief Executive Officer7.2yrsSEK 18.37m1.2%
SEK 132.3m
Fredrik Johansson
Chief Financial Officer6.9yrs데이터 없음0.080%
SEK 8.8m
Lars Stubberud
Head of Technical Operations1.5yrs데이터 없음데이터 없음
Asa Hillsten
Head of IR & Sustainability1.5yrs데이터 없음데이터 없음
Brian Gorman
Group General Counsel1.5yrs데이터 없음데이터 없음
Sandra Frithiof
Head of Human Resources4.5yrs데이터 없음데이터 없음
Ann-Kristin Myde
Head of Clinical Development & VP of Project Management7.5yrs데이터 없음데이터 없음
Richard Philipson
Chief Medical Officer4yrs데이터 없음데이터 없음
Teona Johnson
Head of US Marketing3.3yrs데이터 없음데이터 없음
David Ferraro
Head of US Sales3.3yrs데이터 없음데이터 없음
Monika Tornsen
President of North Americaless than a year데이터 없음데이터 없음
Christopher Ngai
Vice President of Market Accessno data데이터 없음데이터 없음

3.3yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: CALTX 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Diane Parks
Independent Non-Executive Director5.2yrsSEK 795.00k0.031%
SEK 3.5m
Elmar Schnee
Independent Chairman5.2yrsSEK 1.74m0.086%
SEK 9.5m
Henrik Stenqvist
Independent Non-Executive Director2.2yrsSEK 762.00k0.019%
SEK 2.1m
Elisabeth Bjork
Independent Director2.2yrsSEK 587.00k데이터 없음
Jonathan Barratt
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Jürgen Floege
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Richard Lafayette
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Brad Rovin
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Vladimir Tesar
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Hérnan Trimarchi
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Hilde Furberg
Independent Non-Executive Director9.8yrsSEK 731.00k데이터 없음
Heather Reich
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

5.2yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: CALTX 의 이사회는 경험(평균 재직 기간 5.1 년)으로 간주됩니다.